NCT00209222

Efficacy of Rituximab - Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) Versus R-CHOP/R-DHAP in Patients With Untreated Mantle Cell Lymphoma

Nowotwór
chłoniak płaszcza
Chorzy
1sza linia leczenia
Faza badania
III
Sponsor badania
University of Cologne
Termin
-
Linki
www.clinicaltrials.gov
Dane kontaktowe
Jan Walewski;
Ph: +48-22-546-2223;